Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
Titel:
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial
Auteur:
Bosaeed, Mohammad Balkhy, Hanan H Almaziad, Sultan Aljami, Haya A Alhatmi, Hind Alanazi, Hala Alahmadi, Mashael Jawhary, Ayah Alenazi, Mohammed W Almasoud, Abdulrahman Alanazi, Rawan Bittaye, Mustapha Aboagye, Jeremy Albaalharith, Nahla Batawi, Sarah Folegatti, Pedro Ramos Lopez, Fernando Ewer, Katie Almoaikel, Khalid Aljeraisy, Majed Alothman, Adel Gilbert, Sarah C Khalaf Alharbi, Naif
Verschenen in:
Lancet microbe
Paginering:
Jaargang 3 () nr. 1 pagina's e11-e20
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license